MENU

Speakers


  • Vikram Devgan, PhD

    Vikram Devgan, PhD

    Vice President of Global Marketing, Bruker Cellular Analysis

    BIOGRAPHY
  • Stefan Eichmüller, PhD

    Stefan Eichmüller, PhD

    Apl. Professor, Head of the Research Group GMP & T Cell Therapy, Qualified Person German Cancer Research Center (DKFZ), D210, Im Neuenheimer Feld 280, Heidelberg

    BIOGRAPHY
  • Anthony E. Zamora, PhD

    Anthony E. Zamora, PhD

    Assistant Professor, Medical College of Wisconsin, Department of Medicine, Division of Hematology & Oncology, and Department of Microbiology & Immunology

    BIOGRAPHY
  • François Romagné

    François Romagné

    Scientific Director MImAbs

    BIOGRAPHY
  • Xiaoxiao Wang, PhD.

    Xiaoxiao Wang, PhD.

    Vice President of antibody discovery and ADC platform, Nona Bioscience.

    BIOGRAPHY
  • Shu Wang, Ph.D.

    Shu Wang, Ph.D.

    Principal Investigator at Incyte

    BIOGRAPHY
June 04, 2024 | 8:00am PDT | 10:00am CDT | 11:00am EDT | 5:00pm CEST

Antibody and Cell Therapy Development: The Life of Single Cells on Beacon® Platform

Join us as we reveal the revolutionary capabilities of Bruker Cellular Analysis' Beacon Optofluidic system. The Beacon platform provides a complete picture of single cell function through real-time imaging and multi-modal analysis on the same live single cell, with high throughput. Explore its advanced technologies and preset workflows tailored for various applications, including CAR/TCR discovery, T-cell Profiling, antibody discovery, and cell line development. Whether you are an industry expert or an academic researcher, this event promises invaluable insights into cutting-edge advancements shaping the future of antibody and cell therapy development.

Here's what awaits you:

  • Discover how the Beacon platform can elevate your CAR/TCR discovery, T cell profiling, cell therapy, antibody discovery, and cell line development.
  • Hear firsthand from industry experts how function-first assays can drive antibody discovery for difficult targets.
  • Understand why the Beacon instrument is amongst the most widely adopted technologies  for cell line development and has become the Gold Standard.
  • Engage in a live roundtable discussion with academic and industry experts on the technical advancements in single cell functional analysis.
  • Learn about the development of a novel autologous single tumor cell-single T cell co-culture platform, offering real-time visualization of tumor-killing TILs and paving the way for patient-specific T cell immunotherapies.

Speakers
  • Vikram Devgan, PhD

    Vice President of Global Marketing, Bruker Cellular Analysis
    BIOGRAPHY
  • Stefan Eichmüller, PhD

    Apl. Professor, Head of the Research Group GMP & T Cell Therapy, Qualified Person German Cancer Research Center (DKFZ), D210, Im Neuenheimer Feld 280, Heidelberg
    BIOGRAPHY
  • Anthony E. Zamora, PhD

    Assistant Professor, Medical College of Wisconsin, Department of Medicine, Division of Hematology & Oncology, and Department of Microbiology & Immunology
    BIOGRAPHY
  • François Romagné

    Scientific Director MImAbs
    BIOGRAPHY
  • Xiaoxiao Wang, PhD.

    Vice President of antibody discovery and ADC platform, Nona Bioscience.
    BIOGRAPHY
  • Shu Wang, Ph.D.

    Principal Investigator at Incyte
    BIOGRAPHY

You May Also Like

Agenda

  • JUN 04, 2024 11:30 AM PDT

    Roundtable Discussion

    Vikram Devgan, PhD
    Vice President of Global Marketing, Bruker Cellular Analysis
    BIOGRAPHY
    Stefan Eichmüller, PhD
    Apl. Professor, Head of the Research Group GMP & T Cell Therapy, Qualified Person German Cancer Research Center (DKFZ), D210, Im Neuenheimer Feld 280, Heidelberg
    BIOGRAPHY
    Anthony E. Zamora, PhD
    Assistant Professor, Medical College of Wisconsin, Department of Medicine, Division of Hematology & Oncology, and Department of Microbiology & Immunology
    BIOGRAPHY
    François Romagné
    Scientific Director MImAbs
    BIOGRAPHY
    Xiaoxiao Wang, PhD.
    Vice President of antibody discovery and ADC platform, Nona Bioscience.
    BIOGRAPHY
    Shu Wang, Ph.D.
    Principal Investigator at Incyte
    BIOGRAPHY
  • Development of an on-chip binding assay to select clones expressing bispecific antibodies
    JUN 04, 2024 11:00 AM PDT

    Development of an on-chip binding assay to select clones expressing bispecific antibodies

    Shu Wang, Ph.D.
    Principal Investigator at Incyte
    BIOGRAPHY
  • Full human antibody discovery with Beacon and Harbour Mice®
    JUN 04, 2024 10:30 AM PDT

    Full human antibody discovery with Beacon and Harbour Mice®

    Xiaoxiao Wang, PhD.
    Vice President of antibody discovery and ADC platform, Nona Bioscience.
    BIOGRAPHY
  • Accelerating the Antibody Discovery Workflow in the Modern Therapeutic Landscape
    JUN 04, 2024 10:00 AM PDT

    Accelerating the Antibody Discovery Workflow in the Modern Therapeutic Landscape

    François Romagné
    Scientific Director MImAbs
    BIOGRAPHY
  • Leveraging real-time biology to streamline the discovery, validation, and translation of cell-based therapies for cancer
    JUN 04, 2024 9:15 AM PDT

    Leveraging real-time biology to streamline the discovery, validation, and translation of cell-based therapies for cancer

    Anthony E. Zamora, PhD
    Assistant Professor, Medical College of Wisconsin, Department of Medicine, Division of Hematology & Oncology, and Department of Microbiology & Immunology
    BIOGRAPHY
  • Identification of tumor-reactive T cell receptors through functional single cell interaction analyses for personalized T cell therapy
    JUN 04, 2024 8:45 AM PDT

    Identification of tumor-reactive T cell receptors through functional single cell interaction analyses for personalized T cell therapy

    Stefan Eichmüller, PhD
    Apl. Professor, Head of the Research Group GMP & T Cell Therapy, Qualified Person German Cancer Research Center (DKFZ), D210, Im Neuenheimer Feld 280, Heidelberg
    BIOGRAPHY
  • Harnessing the Power of Beacon Platform to Accelerate Antibody Discovery and Cell Therapy Development
    JUN 04, 2024 8:15 AM PDT

    Harnessing the Power of Beacon Platform to Accelerate Antibody Discovery and Cell Therapy Development

    Vikram Devgan, PhD
    Vice President of Global Marketing, Bruker Cellular Analysis
    BIOGRAPHY
  • Poster Number One
    JUN 04, 2024 8:00 AM PDT

    Poster Number One

    Vikram Devgan, PhD
    Vice President of Global Marketing, Bruker Cellular Analysis
    BIOGRAPHY
  • Relative Affinity Ranking of Recombinant Antigen-Specific Antibody Hits with Bruker's Beacon® Optofluidic System
    JUN 04, 2024 8:00 AM PDT

    Relative Affinity Ranking of Recombinant Antigen-Specific Antibody Hits with Bruker's Beacon® Optofluidic System

  • The Beacon® Optofluidic System enables multi-functional characterization of T cells and sequential recovery of single cells from co-culture for downstream transcriptomic analysis
    JUN 04, 2024 8:00 AM PDT

    The Beacon® Optofluidic System enables multi-functional characterization of T cells and sequential recovery of single cells from co-culture for downstream transcriptomic analysis

  • Using Nanoscale Bioreactors to Charactarize Sub-Populations of Cho Clones and Screen Transfected Pools
    JUN 04, 2024 8:00 AM PDT

    Using Nanoscale Bioreactors to Charactarize Sub-Populations of Cho Clones and Screen Transfected Pools

Poster Session

Help

Loading Comments...
Resources

Connect with us on LinkedIn!